New findings from the University of California – Los Angeles Health Sciences finds the menopause transition phase, also known as perimenopause,
Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide,
One Drop, a company developing digital therapeutics solutions for people with diabetes and related conditions, today announced a partnership with
To improve gaps in Type 2 diabetes care within health care systems and to reduce cardiovascular problems for people living with Type 2 diabetes, the
Aerpio Pharmaceuticals, a company focused on developing drugs to treat ocular diseases and diabetic complications, today announced top-line results
Fractyl Laboratories, a private medical technology company based in Lexington, Mass. has started the company’s first U.S. clinical trial for its
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with
Women who find their jobs mentally tiring are more likely to develop Type 2 diabetes, according to a study published in the European Journal of
By: Misti Crane Green tea cut obesity and a number of inflammatory biomarkers linked with poor health in a new study. Mice fed a diet of 2 percent
POPS! Diabetes Care announced the commercial launch of their POPS!® one diabetes management system following FDA clearance in November.
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: